Diego Miralles

Diego Miralles is currently Director at S.V.D.P.
Management, Inc. since 2025, Director at ArrePath, Inc., Director at Contineum Therapeutics, Inc. since 2025, Director at Rady Children's Institute for Genomic Medicine since 2008, President & Head-Research & Development at Artiva Biotherapeutics, Inc. starting 2026, and Venture Partner at CHP Management, Inc. Former roles include President, Chief Executive Officer & Director at Laronde, Inc. from 2020 to 2022, Chief Executive Officer & Director at Vividion Therapeutics, Inc. from 2017 to 2020, Director at NeuBase Therapeutics, Inc. from 2019 to 2021, Medical Director at Triangle Pharmaceuticals, Inc. from 1998 to 2000, Senior Director at Trimeris, Inc. from 2000 to 2005, Advisor at Flagship Pioneering, Inc. from 2022 to 2023, President at Adaptive Therapeutics, Inc. from 2016 to 2017, Assistant Professor at Duke University Medical Center, Member-Management Board at Tibotec Virco Virology BV, and Director at CONNECT.
Education includes a doctorate from Universidad de Buenos Aires conferred in 1986.